Lydia AI Expands Reach in Korea Through Strategic Partnerships with Hecto Data and Tobecon
SEOUL, South Korea--(BUSINESS WIRE)--#canada--Lydia AI, a leading Canadian health AI company, is thrilled to announce…
3 years ago
Wire Stories
InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-332 Meet Primary Endpoint in Patients with Atomic Dermatitis
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment…
3 years ago
FARFETCH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Farfetch Limited and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds…
3 years ago
PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer
– PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial – – Confirmatory trial found…
3 years ago
CORRECTING and REPLACING Aurora, PTT Station, and Royal Umbrella are among the Winners of the 2023 – 2024 World Branding Awards
LONDON--(BUSINESS WIRE)--#worldbranding--Fourth paragraph, first sentence of release dated December 8, 2023, should read: Winners from…
3 years ago
MOGU Announces Unaudited Financial Results for the Six Months Ended September 30, 2023
HANGZHOU, China--(BUSINESS WIRE)--MOGU Inc. (NYSE: MOGU) (“MOGU†or the “Companyâ€), a KOL-driven online fashion and…
3 years ago
Global Manufacturing Execution Systems (MES) Strategic Market Report, 2022 and 2023-2030: Rapidly Changing Dynamics in the Process & Discrete Manufacturing Environments Necessitate MES Deployments – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Manufacturing Execution Systems (MES) - Global Strategic Business Report" has been added to…
3 years ago
Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
If Approved, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Would Offer an…
3 years ago
U.S. FDA Grants Orphan Drug Designation to JR-441 for the Treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA)
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCRâ€) announced…
3 years ago
Rocket Lab Reaches New Annual Launch Record with 10th Electron Mission This Year
The mission successfully deployed a satellite for Japan-based Earth imaging company Institute for Q-shu Pioneers…
3 years ago